R&D

Novartis commits $20M to build a new CAR-T development center at Penn
Fierce Biotech
Fri, 09/12/14 - 08:39 am
Novartis
R&D
CAR-T
Google's stealthy Calico inks an R&D deal for new compounds aimed at neurodegeneration
Fierce Biotech
Thu, 09/11/14 - 05:24 pm
Google
Calico
R&D
neurodegenerative disease
R&D pioneer tackles the next hurdle in gene therapy: Paying for $1M-plus drugs
Fierce Biotech
Thu, 09/11/14 - 08:19 am
R&D
gene therapy
drug pricing
Roche abandons another Fragile X R&D program after PhII trials flunk out
Fierce Biotech
Thu, 09/11/14 - 08:18 am
Roche
Fragile X syndrome
R&D
RG7090
Keytruda Cancer Drug Approval Is A Triumph For Merck: R&D Chief Roger Perlmutter On What's Next
Forbes
Mon, 09/8/14 - 12:28 pm
Merck
Keytruda
R&D
Roger Perlmutter
Piramal, Exelixis And Novo Nordisk Research Woes Spell Doom For Drug Discovery Scientists
Forbes
Thu, 09/4/14 - 08:29 am
Piramal Healthcare
Exelixis
Novo Nordisk
R&D
Google, AbbVie announce research partnership
Marketwatch
Wed, 09/3/14 - 02:20 pm
Google
AbbVie
Calico
R&D
GSK's new Boston collaboration chief goes 'anti-pharma' as he prowls for partners
Fierce Biotech
Wed, 09/3/14 - 10:40 am
GSK
Boston
R&D
Novo Nordisk to exit inflammatory disease research
Pharmaphorum
Tue, 09/2/14 - 08:07 am
Novo Nordisk
R&D
inflammatory disease
NN8226
ThromboGenics spins out cancer R&D, scales down staff amid lackluster Jetrea sales
Fierce Biotech
Mon, 09/1/14 - 10:52 am
ThromboGenics
layoffs
R&D
CytRx is pouring money into R&D of cancer-fighting drugs
LA Times, CA
Mon, 09/1/14 - 09:52 am
R&D
cancer
CytRx
The real 'exclusive' at Merck: R&D is back in the saddle, baby
Fierce Biotech
Mon, 08/25/14 - 08:48 am
Merck
R&D
melanoma
Pembrolizumab
Global fear of Ebola outbreak stokes a frenzy of new R&D, production plans
Fierce Biotech
Thu, 08/21/14 - 08:12 am
R&D
ebola virus
Mapp Biopharmaceutical
Tekmira Pharmaceuticals
The Negative Impact Of Pfizer's Mergers And Budget Cuts On Cancer R&D
Forbes
Tue, 08/19/14 - 08:41 am
Pfizer
M&A
R&D
AstraZeneca
Politicians Shouldn't Question Drug Costs But Rather Their Value. Lessons From Soliris And Sovaldi.
Forbes
Mon, 08/4/14 - 09:37 am
Sovaldi
Soliris
R&D
FDA says 'stands ready' to work with companies developing Ebola drugs
Yahoo/Reuters
Mon, 08/4/14 - 08:55 am
FDA
ebola virus
R&D
Beyond the Q2 numbers, three big questions for Pfizer
Fierce Pharma
Tue, 07/29/14 - 02:30 pm
Pfizer
R&D
earnings
'Do Drug Companies Make Drugs, Or Money?'
Forbes
Tue, 07/29/14 - 10:03 am
Big Pharma
profits
R&D
The Pfizer dilemma: Spurned by AstraZeneca, revenue falling and facing an R&D crisis
Fierce Biotech
Mon, 07/28/14 - 01:19 pm
Pfizer
AstraZeneca
R&D
Drugmakers to share neglected compounds with British academia
Yahoo/Reuters
Tue, 07/22/14 - 08:47 am
UK
R&D
AstraZeneca
GSK
JNJ
Eli Lilly
Pfizer
Takeda
UCB Pharmaceuticals

Pages